These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8291095)

  • 1. Further studies of veto activity in rhesus monkey bone marrow in relation to allograft tolerance and chimerism.
    Thomas JM; Carver FM; Kasten-Jolly J; Haisch CE; Rebellato LM; Gross U; Vore SJ; Thomas FT
    Transplantation; 1994 Jan; 57(1):101-15. PubMed ID: 8291095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for transforming growth factor-beta in the veto mechanism in transplant tolerance.
    Verbanac KM; Carver FM; Haisch CE; Thomas JM
    Transplantation; 1994 Mar; 57(6):893-900. PubMed ID: 8154038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney allograft tolerance in primates without chronic immunosuppression--the role of veto cells.
    Thomas JM; Carver FM; Cunningham PR; Olson LC; Thomas FT
    Transplantation; 1991 Jan; 51(1):198-207. PubMed ID: 1824804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoregulatory role of CD8alpha in the veto effect.
    Asiedu C; Meng Y; Wang W; Huang Z; Contreras JL; George JF; Thomas JM
    Transplantation; 1999 Feb; 67(3):372-80. PubMed ID: 10030281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The facilitating effect of one-DR antigen sharing in renal allograft tolerance induced by donor bone marrow in rhesus monkeys.
    Thomas JM; Verbanac KM; Smith JP; Kasten-Jolly J; Gross U; Rebellato LM; Haisch CE; Carver FM; Thomas FT
    Transplantation; 1995 Jan; 59(2):245-55. PubMed ID: 7839448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Split tolerance induced by immunotoxin in a rhesus kidney allograft model.
    Fechner JH; Vargo DJ; Geissler EK; Graeb C; Wang J; Hanaway MJ; Watkins DI; Piekarczyk M; Neville DM; Knechtle SJ
    Transplantation; 1997 May; 63(9):1339-45. PubMed ID: 9158030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of linked suppression in addition to the donor H-2 class I-specific unresponsiveness in recipient T cells by transfusing class I plus class II-disparate, but not class I alone-disparate, bone marrow cells.
    Muraoka S
    Cell Immunol; 1990 Jun; 128(1):261-76. PubMed ID: 1971530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical studies of allograft tolerance in rhesus monkeys: a novel anti-CD3-immunotoxin given peritransplant with donor bone marrow induces operational tolerance to kidney allografts.
    Thomas JM; Neville DM; Contreras JL; Eckhoff DE; Meng G; Lobashevsky AL; Wang PX; Huang ZQ; Verbanac KM; Haisch CE; Thomas FT
    Transplantation; 1997 Jul; 64(1):124-35. PubMed ID: 9233712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient.
    Burlingham WJ; Grailer AP; Fechner JH; Kusaka S; Trucco M; Kocova M; Belzer FO; Sollinger HW
    Transplantation; 1995 Apr; 59(8):1147-55. PubMed ID: 7732562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pretreatment of murine donor grafts with L-leucyl-L-leucine methyl ester: elimination of graft-versus-host disease without detrimental effects on engraftment.
    Blazar BR; Thiele DL; Vallera DA
    Blood; 1990 Feb; 75(3):798-805. PubMed ID: 1967541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of allogeneic bone marrow labeled with neomycin resistance gene to examine bone marrow-derived chimerism in experimental organ transplantation.
    Smith JP; Kasten-Jolly J; Rebellato L; Haisch CE; Thomas JM
    Cell Transplant; 1997; 6(4):369-76. PubMed ID: 9258510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Converting nonhuman primate dendritic cells into potent antigen-specific cellular immunosuppressants by genetic modification.
    Clement A; Pereboev A; Curiel DT; Dong SS; Hutchings A; Thomas JM
    Immunol Res; 2002; 26(1-3):297-302. PubMed ID: 12403367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Veto cells in transplantation tolerance.
    Thomas JM; Verbanac KM; Carver FM; Kasten-Jolly J; Haisch CE; Gross U; Smith JP
    Clin Transplant; 1994 Apr; 8(2 Pt 2):195-203. PubMed ID: 8019036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Donor specific bone marrow cells suppress lymphocyte reactivity to donor antigens and differentially modulate TH1 and TH2 cytokine gene expression in the responder cell population.
    Lagoo-Deenadayalan S; Lagoo AS; Lemons JA; Lorenz HM; Bass JD; McDaniel DO; Hardy KJ; Barber WH
    Transpl Immunol; 1995 Jun; 3(2):124-34. PubMed ID: 7582903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses.
    Mathew JM; Garcia-Morales R; Fuller L; Rosen A; Ciancio G; Burke GW; Carreno M; Temple D; Tzakis AG; Ricordi C; Miller J; Esquenazi V
    Transplantation; 2000 Dec; 70(12):1675-82. PubMed ID: 11152096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of incompatible allograft acceptance in rhesus monkeys given posttransplant antithymocyte globulin and donor bone marrow. II. Effects of adjuvant immunosuppressive drugs.
    Thomas JM; Carver M; Cunningham P; Sash C; Park K; Thomas F
    Transplantation; 1989 Feb; 47(2):209-15. PubMed ID: 2645699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of skin xenograft tolerance in rat-to-mouse combination could be affected by DFR mediating cells and antibodies against rat bone marrow cells as well as NK cells in the cyclophosphamide-induced tolerance system.
    Nishimura Y; Eto M; Maeda T; Hiromatsu K; Nomoto K; Kong YY; Nomoto K
    Immunobiology; 1995 Aug; 193(5):420-38. PubMed ID: 8522358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor MHC class II antigen is essential for induction of transplantation tolerance by bone marrow cells.
    Umemura A; Monaco AP; Maki T
    J Immunol; 2000 May; 164(9):4452-7. PubMed ID: 10779744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus.
    Fukuzaki T; Hancock WW; Monaco AP; Maki T
    Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.